← All Sponsors
SPONSOR

Zai Lab (Hong Kong), Ltd.

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Community-acquired Bacterial Pneumonia

Clinical Trials by Zai Lab (Hong Kong), Ltd.

NCT06162286 Phase 3
Recruiting

A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP

Community-acquired Bacterial Pneumonia
China View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology